0001493152-20-009778.txt : 20200522 0001493152-20-009778.hdr.sgml : 20200522 20200522192240 ACCESSION NUMBER: 0001493152-20-009778 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200520 FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Opaleye Management Inc. CENTRAL INDEX KEY: 0001595855 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 20907593 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: SUITE 2600 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-904-9195 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: SUITE 2600 CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW HEALTH, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 4 1 ownership.xml X0306 4 2020-05-20 0 0001360214 HARROW HEALTH, INC. HROW 0001595855 Opaleye Management Inc. ONE BOSTON PLACE, 26TH FLOOR BOSTON MA 02108 0 0 1 0 Common Stock, par value $0.0001 per share 2020-05-20 4 P 0 300 4.47 A 2480800 I By Opaleye, L.P. Common Stock, par value $0.0001 per share 2020-05-20 4 P 0 1200 4.4981 A 119800 I By Managed Account Common Stock, par value $0.0001 per share 2020-05-21 4 P 0 10396 4.6555 A 2491196 I By Opaleye, L.P. Common Stock, par value $0.0001 per share 2020-05-21 4 P 0 200 4.6981 A 120000 I By Managed Account Common Stock, par value $0.0001 per share 2020-05-22 4 P 0 8804 5.0527 A 2500000 I By Opaleye, L.P. Common Stock, par value $0.0001 per share 2020-05-22 4 P 0 5000 5.021 A 125000 I By Managed Account The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $4.47. The range of purchase prices on the transaction date was $4.40 to $4.505 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $4.6555. The range of purchase prices on the transaction date was $4.605 to $4.747 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.0527. The range of purchase prices on the transaction date was $4.72 to $5.34 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.021. The range of purchase prices on the transaction date was $4.70 to $5.20 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. Opaleye Management Inc., By: /s/ James Silverman, President 2020-05-22